Lipopolysaccharide-binding protein (LBP) and bactericidal/permeability-increasing protein (BPI) are closely related endotoxin-binding proteins that function in a co-ordinated manner to facilitate an integrated host response to invading Gram-negative bacteria. Differences in the structure and function of BPI and LBP, as well as differences in their mobilization, permit highly sensitive pro-inflammatory responses to small numbers of bacteria at the onset of bacterial invasion and, later, efficient elimination of viable bacteria and their remnants and of endotoxin-driven inflammation.
Introduction
Multicellular organisms are continuously challenged by the intrusion of micro-organisms that abound in the surrounding environment. When this includes microbes that can proliferate rapidly outside host cells, even the incursion of a few organisms can soon pose a risk if microbial multiplication proceeds unabated. To combat this problem, multicellular organisms have evolved highly efficient machinery to selectively recognize invading micro-organisms, and to couple microbial recognition to the mobilization of host defence systems permitting elimination of viable microbes and their remnants before appreciable proliferation and dissemination ensues. For defence against many invading Gram-negative bacteria (GNB), the recognition of endotoxins, unique surface glycolipids of GNB, has provided a key strategy linked to the induction of inflammation, targeting of GNB for elimination and clearance of the endotoxin itself ( Figure 1 ).
Endotoxins of GNB
Endotoxins [lipopolysaccharides (LPSs) and lipo-oligosaccharides (LOSs)] are present only in GNB, where they occupy much of the outer leaflet of the unique outer membrane (OM) of GNB [1] (Figure 2 ). Endotoxins are composed of a conserved lipid A region, a β1→6-linked disaccharide of N-acetylglucosamine substituted with non-hydroxylated and 3-OH fatty acids in amide and ester linkages, and a carbohydrate chain of variable length and composition, including several acidic groups in close proximity to lipid A. Host endotoxin-binding proteins, such as lipopolysaccharide-binding protein (LBP) and bactericidal/permeability-increasing protein (BPI), confer broad-range innate immune recognition of GNB by interacting with sites within the conserved inner core sugar and lipid A regions [2] . The extension of long polysaccharide chains from OM LPS impedes binding of BPI and LBP and, hence, in the absence of specific carbohydratedirected antibodies, increases bacterial resistance to innate immune recognition and clearance [3, 4] .
The amphipathic nature of endotoxin normally precludes presentation of endotoxin in isolated monomolecular form. The lipid A region is embedded in the outer leaflet of the OM or, after extraction and purification, is sequestered within large aggregates [5] . The close proximity of several anionic moieties within the inner core and lipid A regions creates high-affinity (micromolar) binding sites for Ca 2+ and/or Mg 2+ . These bivalent cations are needed for dense packing of endotoxin within the bacterial OM and aggregates [6] . Thus recognition of endotoxin by host endotoxin-binding proteins may reflect a complex molecular paradigm in which interfacial properties conferred by neighbouring endotoxin molecules or other molecules associated with endotoxin regulate protein-endotoxin interactions.
Molecular basis of the pro-inflammatory action of endotoxin: role of LBP
The cumulative work of many laboratories has implicated four host proteins -LBP, CD14, MD-2 and Toll-like receptor 4 (TLR4) -as key factors in mammalian cell activation by endotoxin [7] [8] [9] [10] . Other extracellular and/or cell-surface host proteins may also participate, depending on specific structural features of particular endotoxin species and, perhaps, the host cell and response examined [1, 11] . LBP, CD14 and MD-2 can each bind to purified endotoxin, but only LBP, by itself, can bind to purified endotoxin aggregates and endotoxin-rich membranes with an affinity consistent with sensitive recognition [12, 13] . Maximum sensitivity of endotoxin signalling requires the concerted and ordered action of all of these proteins, implying that cellular receptors containing TLR4 can only recognize and respond to small (pg/ml) amounts of endotoxin after modification of endotoxin by LBP, CD14 and, perhaps, MD-2 [14] (Figure 3 ). LBP is a 60 kDa glycoprotein that is synthesized principally by hepatocytes [15] . LBP binds directly to the OM of GNB and to purified aggregates of extracted endotoxin, and catalyses the delivery of endotoxin to membrane (mCD14; glycosylphosphatidylinositol-linked) and soluble (sCD14) forms of CD14 [15, 16] (Figure 3 ), thereby markedly increasing host cell sensitivity to endotoxin. In cells that lack mCD14, LBP-and sCD14-dependent activation of TLR4(+)/MD-2(+) cells (e.g. many endothelial cells) correlates closely with LBP-and sCD14-dependent extraction of endotoxin from endotoxin-rich monolayers to form monomeric endotoxin-sCD14 complexes [5, 14] (Figure 3 ). Purified endotoxin-sCD14 directly activates TLR4(+)/MD-2(+) cells at pg/ml endotoxin doses, indicating that the role of LBP in endotoxin-dependent cell activation is simply to catalyse formation of these complexes. Purified endotoxin aggregates in the presence or absence of LBP or sCD14 are not able to produce similar cell activation, even at 100-1000 times higher endotoxin doses, consistent with the view that efficient engagement of TLR4 and/or MD-2 requires presentation of endotoxin in complex with CD14. The conversion of large endotoxin aggregates containing thousands of endotoxin molecules/aggregate into monomeric endotoxinsCD14 complexes is remarkably efficient, occurring within a few minutes at 37
• C at concentrations of endotoxin, LBP and sCD14 that are likely to be physiologically relevant ( [5, 14, 17] ; see below). Whether or not release of endotoxinsCD14 complexes also follows delivery of LBP-endotoxin aggregates to mCD14 and, if so, is required for TLR4-dependent cell activation is not yet known. However, a monoclonal antibody to CD14 (18E12) that binds to endotoxin-sCD14 blocks both mCD14-and sCD14-dependent cell activation by endotoxin, suggesting that each depends on similar molecular transformations of endotoxin.
LBP and m/sCD14 can also promote potent activation of host cells by intact, live GNB and by isolated, extruded OM 'blebs' [18, 19] . In some circumstances, cell activation by intact bacteria is more potent than that by a corresponding amount of purified endotoxin isolated from the same bacteria [18] , suggesting a possible role for other bacterial constituents in delivery of endotoxin-rich bacterial membranes to host cells and/or subsequent signalling events [20] . However, in other cases, LBP-and CD14-dependent cell activation by purified endotoxin is more potent than that by purified OM blebs, because LBP-dependent delivery and/or extraction of endotoxin to form bioactive endotoxin-(s)CD14 complexes is more efficient with purified endotoxin [19] .
LBP efficiently catalyses the transfer of individual molecules of endotoxin to (s)CD14 only when LBP-endotoxin aggregates are formed in the presence of albumin [14] . One possible explanation for this role of albumin is that it is needed to maintain an 'activated' state of LBPendotoxin aggregates, permissive for extraction and transfer of endotoxin to (s)CD14. In the presence of EDTA (i.e. absence of stabilizing bivalent cations), LBP binding promotes further disaggregation of endotoxin [21, 22] . LBP binding does not have such drastic effects under more physiological conditions, but may still induce more subtle topological rearrangements of endotoxin. The fact that albumin must be present -as it is physiologically -when endotoxin-LBP interactions take place is compatible with the hypothesis that the 'active' configuration of LBP-endotoxin aggregates is one in which lipophilic groups within lipid A have become more exposed. In the absence of albumin, this configuration would be unstable and short-lived, triggering further rearrangements of endotoxin within LBP-endotoxin aggregates that would render it refractory to disaggregation with sCD14 even when albumin is subsequently added [14] .
BPI
An important LBP-dependent pro-inflammatory action of endotoxin is the acute mobilization of circulating polymorphonuclear leucocytes (PMN; neutrophils) to tissue sites of bacterial invasion [23, 24] . These cells play an essential role in the timely arrest of bacterial proliferation and the sequestration of bacteria for eventual disassembly, degradation and clearance. Among the prominent antimicrobial constituents of these highly specialized host defence cells is BPI [25] . BPI is stored within the primary granules of PMN, and can be mobilized to the phagocytic vacuole to contribute to intracellular bacterial destruction and, to a lesser extent, to the extracellular fluid of PMN-rich inflammatory exudates. Recent studies indicate a wider range of BPI expression and mobilization [26] , implying an even broader arena for BPI function.
BPI is the closest known relative of LBP, and shares the ability to bind unmodified endotoxin aggregates, isolated OM and intact, live GNB, but with an appreciably higher affinity than that displayed by LBP [2, 27] . The most significant differences between BPI-endotoxin and LBPendotoxin interactions are in the functional consequences of these interactions. BPI binding to GNB initiates first sublethal, then lethal, bacterial injury [25] , whereas equivalent amounts of LBP binding have no apparent cytotoxic effect. Both BPI and LBP can have opsonic effects (i.e. can enhance the uptake of bacteria by phagocytic cells), but LBP-coated GNB are taken up mainly by monocytes or macrophages (rather than by PMN) via mCD14 [28] , whereas BPIcoated GNB are taken up mainly by PMN independent of mCD14 [27] . BPI binding to endotoxin apparently precludes delivery of endotoxin to CD14, formation of endotoxin-CD14 complexes and cell activation by endotoxin [22, 27] (Figure 3 ). BPI is a very potent inhibitor of CD14-dependent cell activation by endotoxin because of both its high affinity for endotoxin-rich particles and the ability of substoichiometric binding of BPI to endotoxin-rich monolayers to block LBP-dependent interactions of endotoxin with CD14 and cell activation [21] . BPI promotes the CD14-independent delivery of purified endotoxin aggregates to host cells without apparent cell activation [22] . Among blood cells, the major cellular targets of BPI-endotoxin aggregates are monocytes [22, 29] , indicating two different pathways for BPI-endotoxin particles, depending on the nature of the endotoxin-rich particle to which BPI is bound. Only a small fraction of BPI-endotoxin aggregates is typically taken up by monocytes; whether more efficient elimination of cell-free endotoxin bound to BPI is accomplished by tissue derivatives of monocytes that are are present where BPI-endotoxin complexes accumulate [30, 31] or when endotoxin is still OMassociated remains to be determined.
Structural bases of differences in BPI compared with LBP function?
BPI and LBP share nearly 50% primary structural identity [2, 7, 32] . Molecular modelling suggests that the tertiary structure of LBP is closely similar to the extended boomeranglike structure of BPI revealed by X-ray crystallography [32] [33] [34] . Each protein has two domains, each of which comprises approx. 200 amino acids. The N-terminal domain of each protein binds GNB and purified aggregates of endotoxin, whereas the C-terminal domain mediates delivery of endotoxin to other host molecules [2, 22, 29, [35] [36] [37] . Conserved basic residues clustered at the far end of the Nterminal domain are believed to mediate initial electrostatic interactions of BPI and LBP with acidic sites clustered near the lipid A region [25, [32] [33] [34] 38 ] (see Figure 2) . However, the overall net charge of the N-terminal domain of BPI is much more cationic than that of LBP, reflecting a much broader cationic surface as well as a greater net positive charge density ( [25] ; T. Cardozo and J. Weiss, unpublished work). These differences presumably account for the higher affinity of BPI compared with LBP for interactions with endotoxin-rich monolayers, and possibly also the more disruptive effects that BPI has on the OM. A fragment of BPI obtained by either limited proteolysis or expression in recombinant form (containing residues 1-191) has all of the endotoxin/GNBbinding, neutralizing and cytotoxic properties of holo-BPI (456 residues) [35, 39, 40] . In fact, the fragment is more potent than holo-BPI against several strains and species of GNB expressing long-chain LPSs, because the BPI fragment is less impeded than holo-BPI from reaching the OM interface by the long polysaccharide chains of LPS [3] . These properties have encouraged a determined effort to develop a bioactive recombinant BPI derivative (rBPI21; Neuprex) for use in treatment of diseases where endogenous mechanisms are inadequate for the elimination of GNB and/or bioactive endotoxin [41, 42] .
Comparisons of the functional properties of LBP, BPI and LBP/BPI chimaeras have revealed an apparently specific role of the C-terminal domain of LBP in the binding of CD14 to LBP-endotoxin aggregates and in the formation of bioactive monomeric endotoxin-CD14 complexes [22] . These studies suggest two inter-related roles of the C-terminal domain of LBP: (1) promotion of reversible docking of CD14 to membranes/aggregates containing endotoxin; and (2) destabilization of endotoxin-rich monolayers, facilitating the extraction and delivery of individual molecules of endotoxin to CD14. The precise properties of LBP-modified endotoxinrich monolayers that promote interaction with CD14 (e.g. modification of endotoxin arrangement by LBP and/or the clustering of LBP on these surfaces) are not known. Apart from the distal cationic tip of the N-terminal domain that provides initial electrostatic attraction, extended surfaces of LBP within both the N-and C-terminal domains have a net negative charge and may contribute to monolayer destabilization by electrostatic repulsion. Of note is the fact that the bioactive N-terminal region of CD14 is highly anionic [43] , suggesting that association of CD14 could further increase, by electrostatic repulsion, the interface instability initiated by LBP, and thereby promote the release of bioactive endotoxin-CD14 complexes.
Regulation of co-ordinated LBP and BPI function during the host response to invading GNB
The properties of LBP and BPI described above suggest a relatively simple model of their co-ordinated function, which permits an efficient response to and elimination of invading GNB and a return to homoeostasis. Studies with knockout mice support the concept that LBP [23, 24] , along with CD14, MD-2 and TLR4, is needed in order to mount an acute inflammatory response promptly after inoculation of small (≈10 2 ) numbers of GNB, triggering a timely mobilization of PMN, etc., that leads to the elimination of viable GNB and their remnants, including endotoxin. The potency of LBP-dependent cell activation by endotoxin is all the more remarkable given that, under many in vitro conditions that have been employed, the vast majority of endotoxin delivered to cells via LBP (and CD14) is internalized without contributing to cell activation [44, 45] . In fact, if the host cell contains the LPS deacylase acyloxyacyl hydrolase (e.g. macrophages), bulk clearance of endotoxin is coupled to partial deacylation and detoxification, converting endotoxin from a potent agonist into a potent antagonist, and thus potentially further decreasing cellular responsiveness to endotoxin [31] . How is pg/ml sensitivity to endotoxin achieved, particularly at tissue sites of initial bacterial invasion where local LBP concentrations are likely to be only a fraction of constitutive levels of LBP (approx. 1-5 µg/ml) in plasma? Examination of this question in vitro has revealed that maximum cell activation by endotoxin requires at least equimolar (to endotoxin) quantities of CD14, but very low LBP concentrations, corresponding to as little as 1 mol of LBP/100 mol of endotoxin [17] . These conditions favour the formation and accumulation of bioactive endotoxin-CD14 complexes that activate cells in a CD14-and TLR4-dependent fashion, with little net cellular uptake of endotoxin. Increasing concentrations of LBP -as occurs during the acute-phase response -trigger the accumulation of endotoxin aggregates or bacterial membranes containing LBP (and CD14) that are taken up in a CD14-and TLR4-independent manner without inducing pro-inflammatory responses. Therefore, quantitative changes in LBP concentration (LBP/CD14 ratio), as occur during the host response to invading GNB, qualitatively change LBP function from catalysing the formation of pro-inflammatory endotoxin-CD14 complexes to reacting stoichiometrically with endotoxin to direct its 'silent' elimination [46] . These findings strongly suggest that the host machinery linked to TLR4-dependent cellular activation or TLR4-independent cellular clearance of endotoxin selectively recognizes different protein-endotoxin complexes. At the outset of infection, the low concentrations of LBP present and the absence of extracellular BPI favour the formation of pro-inflammatory endotoxin-CD14 complexes. The mobilization of BPI and LBP that is triggered by inflammation directs endotoxin and other bacterial OMassociated remnants for clearance, and hence resolution of endotoxin-triggered inflammation (Figure 3) . In this circumstance, the fates of BPI-and LBP-coated endotoxin aggregates and bacterial membranes appear to be similar, raising the possibility that endotoxin clearance mechanisms exist that recognize shared structural traits of BPI-endotoxin and LBP-endotoxin aggregates and membranes.
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